| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |